Eagle Claw Capital Managment, LLC Novartis Ag Transaction History
Eagle Claw Capital Managment, LLC
- $598 Million
- Q4 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Novartis Ag stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 25,134 shares of NVS stock, worth $2.74 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
25,134
Previous 22,434
12.04%
Holding current value
$2.74 Million
Previous $2.58 Million
5.23%
% of portfolio
0.41%
Previous 0.45%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,477Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$892 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...